Notice 2 Apr 2025 compliance, healthcare, ohio, dea, legal, medical licensing

⚖️DEA Revocation of Registration for Dr. Lager-Fermon in Ohio

The Drug Enforcement Administration issued an Order to Show Cause to Dr. Jennifer Marie Lager-Fermon, which proposed revoking her DEA registration due to the indefinite suspension of her Ohio medical license. Consequently, she is no longer authorized to prescribe controlled substances, and the Agency's findings confirmed her default following the lack of a hearing request.

Learn More
Notice 31 Mar 2025 regulatory, health, insurance, business, compensation, legal, vaccine

💉National Vaccine Injury Compensation Program

HRSA is publishing this notice of petitions received under the National Vaccine Injury Compensation Program (the Program), as required by the Public Health Service (PHS) Act, as amended. While the Secretary of HHS is named as the respondent in all proceedings brought by the filing of petitions for compensation under the Program, the United States Court of Federal Claims is charged by statute with responsibility for considering and acting upon the petitions.

Learn More
Notice 19 Mar 2025 compliance, repatriation, industry regulations, native american, cultural heritage, museum, legal

🏺Notice of Inventory Completion by Peabody Museum of Harvard University

In accordance with the Native American Graves Protection and Repatriation Act (NAGPRA), the Peabody Museum of Archaeology and Ethnology, Harvard University (PMAE) has completed an inventory of human remains and has determined that there is a cultural affiliation between the human remains and Indian Tribes or Native Hawaiian organizations in this notice. The human remains were collected at the Sherman Institute, Riverside County, CA.

Learn More
Notice 19 Mar 2025 compliance, repatriation, nabrpa, native american, museums, cultural heritage, legal, cultural institutions

🏺Notice of Inventory Completion by Peabody Museum under NAGPRA

In accordance with the Native American Graves Protection and Repatriation Act (NAGPRA), the Peabody Museum of Archaeology and Ethnology, Harvard University (PMAE) has completed an inventory of human remains and has determined that there is a cultural affiliation between the human remains and Indian Tribes or Native Hawaiian organizations in this notice. The human remains were collected at the Uintah and Ouray Agency, Uintah County, UT, Sherman Institute, Riverside County, CA, University of New Mexico, Alburquerque County, NM, and U.S. Indian Vocational School, Alburquerque County, NM.

Learn More
Notice 18 Mar 2025 compliance, regulation, financial services, arbitration, finra, legal

⚖️FINRA Proposes Accelerated Arbitration Rules for Older and Ill Parties

The SEC published a notice regarding FINRA's proposed rule change to amend the Codes of Arbitration Procedure, enabling accelerated processing for arbitration cases involving parties aged 70 or older or those with qualifying health conditions. This rule aims to shorten arbitration timelines significantly, enhancing accessibility for vulnerable populations in financial disputes.

Learn More
Notice 14 Mar 2025 compliance, regulatory, immigration, non-profit, accreditation, legal

📋Information Collection Activities for Non-Attorney Representatives

The Executive Office for Immigration Review (EOIR), Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.

Learn More
Notice 14 Mar 2025 compliance, healthcare, regulation, government, health, legal

⚖️Overview of HHS Office of General Counsel's Organization and Authority

This document revises and restates the Statement of Organization, Functions, and Delegations of Authority for the Department of Health and Human Services, Office of the General Counsel (OGC). Issuance of this Statement of Organization rescinds all prior Statements of Organization.

Learn More
Notice 13 Mar 2025 compliance, regulation, fda, debarment, pharmaceutical, drug importation, legal

⚖️FDA Debarment Order Against Jonathan Corbett Cosie

The Food and Drug Administration (FDA) is issuing an order under the Federal Food, Drug, and Cosmetic Act (FD&C Act) debarring Jonathan Corbett Cosie for a period of 10 years from importing or offering for import any drug into the United States. FDA bases this order on a finding that Mr. Cosie was convicted of two felony counts under Federal law for introducing misbranded drugs into interstate commerce with the intent to defraud and mislead. The factual basis supporting Mr. Cosie's conviction, as described below, is conduct relating to the importation into the United States of a drug or controlled substance. Mr. Cosie was given notice of the proposed debarment and was given an opportunity to request a hearing to show why he should not be debarred. As of January 6, 2025 (30 days after receipt of the notice), Mr. Cosie had not responded. Mr. Cosie's failure to respond and request a hearing constitutes a waiver of his right to a hearing concerning this matter.

Learn More
Notice 13 Mar 2025 compliance, fda, debarment, health, sanctions, drug regulation, legal

⚖️Implications of John Kosolcharoen's FDA Debarment Order

The Food and Drug Administration (FDA) is issuing an order under the Federal Food, Drug, and Cosmetic Act (FD&C Act) permanently debarring John Warrington Kosolcharoen from providing services in any capacity to a person that has an approved or pending drug product application including, but not limited to, a biologics license application (BLA). FDA bases this order on a finding that Mr. Kosolcharoen was convicted of a felony under Federal law for conduct that relates to the regulation of a drug product under the FD&C Act. Mr. Kosolcharoen was given notice of the proposed debarment and an opportunity to request a hearing within the timeframe prescribed by regulation. As of December 26, 2024 (30 days after receipt of the notice), Mr. Kosolcharoen has not responded. Mr. Kosolcharoen's failure to respond and request a hearing constitutes a waiver of Mr. Kosolcharoen's right to a hearing concerning this matter.

Learn More
Notice 13 Mar 2025 compliance, fda, debarment, pharmaceutical, drug regulation, importation, legal

🚫FDA Debars Alnashir Punjani for 5 Years

The Food and Drug Administration (FDA or the Agency) is issuing an order under the Federal Food, Drug, and Cosmetic Act (FD&C Act) debarring Alnashir Alibhai Punjani for a period of 5 years from importing or offering for import any drug into the United States. FDA bases this order on a finding that Mr. Punjani was convicted of one felony count under Federal law for conspiracy to deliver and introduce unapproved drugs. The factual basis supporting Mr. Punjani's conviction, as described below, is conduct relating to the importation into the United States of a drug or controlled substance. Mr. Punjani was given notice of the proposed debarment and was given an opportunity to request a hearing to show why he should not be debarred. As of November 10, 2024 (30 days after receipt of the notice), Mr. Punjani had not responded. Mr. Punjani's failure to respond and request a hearing constitutes a waiver of his right to a hearing concerning this matter.

Learn More